ABMD Financial Facts
Investment income (expense), net: 342KNet loss: 8.88M
See Full Income Statement
Accrued expenses: 28.01M
Accumulated deficit: -77.29M
See Full Balance Sheet
Abiomed Inc. (ABMD) Earnings
|
Expand Research on ABMD
| Next EPS Date | N/A | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +11.0% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +1.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
1/28/15  |
 |
Q315 | $0.30 | $0.04 | +$0.26 | $62M | $53.2M |  |
 | | Details |
| 10/30/14 |
|
Q215 | $0.03 | $0.02 | +$0.01 | $51.8M | $48.8M | |
| | Details |
| 5/5/15 |
|
Q415 | $2.24 | $0.14 | +$2.10 | $67.6M | $62.55M | N/A | | | Details |
| 8/4/15 |
Q116 | $0.20 | $0.08 | +$0.12 | $73.4M | $66.27M | N/A | | | Details | |
| 10/31/19 | |
Q220 | $0.28 | $0.93 | -$0.65 | $205M | $206.45M | = | | | Details |
| 4/30/20 | |
Q420 | $0.70 | $0.94 | -$0.24 | $206.7M | $207.17M | N/A | | | Details |
| 5/3/18 | Q418 | $0.80 | $0.64 | +$0.16 | $174.4M | $164.31M | = | | | Details | |
| 11/1/18 | |
Q219 | $1.09 | $0.74 | +$0.35 | $181.8M | $175.22M | = | | | Details |
